Online first
Clinical vignette
Published online: 2024-11-25

open access

Page views 30
Article views/downloads 23
Get Citation

Connect on Social Media

Connect on Social Media

Clinical outcomes and long-term follow-up after radioligand therapy in aggressive non-functioning pituitary neuroendocrine tumour

Dorota Brodowska-Kania1, Marek Saracyn1, Natalia Osial1, Adam Daniel Durma1, Maciej Kołodziej1, Grzegorz Kamiński1

Abstract

Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file

References

  1. Raverot G, Burman P, McCormack A, et al. European Society of Endocrinology. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 2018; 178(1): G1–G24.
  2. Nakano-Tateno T, Lau KJ, Wang J, et al. Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors. Front Endocrinol (Lausanne). 2021; 12: 624686.
  3. Harris PE, Zhernosekov K. The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next? Front Endocrinol (Lausanne). 2022; 13: 941832.
  4. Marques P. The Effects of Peptide Receptor Radionuclide Therapy on the Neoplastic and Normal Pituitary. Cancers (Basel). 2023; 15(10).
  5. Ilie MD, Raverot G. Treatment Options for Gonadotroph Tumors: Current State and Perspectives. J Clin Endocrinol Metab. 2020; 105(10).